Optimal treatment for advanced seminoma?
نویسندگان
چکیده
منابع مشابه
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
J. Oldenburg1, S. D. Fosså1, J. Nuver2, A. Heidenreich3, H-J Schmoll4, C. Bokemeyer5, A. Horwich6, J. Beyer7 & V. Kataja8, on behalf of the ESMO Guidelines Working Group* Department of Oncology, Oslo University Hospital, Oslo, Norway; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands; Department of Urology, RWTH University Hospital, Aachen; Departme...
متن کاملBest treatment option for clinical stage I seminoma patients
In the present cross sectional study comprising 106 patients, the authors compared a risk adapted therapeutic strategy in patients with CSI seminoma [1]. The patients were distributed to active surveillance (AS) (n = 84) and adjuvant chemotherapy (ACT) (n = 22) with single dose carboplatin groups. The relapse rates between the 2 groups were similar. The authors advocated AS for patients with lo...
متن کاملChoosing Treatment for Stage I Seminoma: Who Should Get What?
Lawrentschuk and Fleshner accurately depict the difficulty in choosing among observation, prophylactic radiation, and adjuvant chemotherapy for clinical stage I testicular seminoma. The physican has competing priorities of avoiding unnecessary treatment while minimizing the overall burden of both therapy and surveillance testing. The patient has to contend with defined risks that exist with any...
متن کاملChoosing treatment for stage I seminoma: who should get what?
We agree that physicians should choose active surveillance for their patients if they have the means to afford health insurance and are relatively stable within their careers. Prophylactic radiotherapy should be offered to patients who need a relaxed follow-up schedule for financial, emotional, or compliance reasons. For adjuvant carboplatin, longer follow-up data are needed to better define su...
متن کاملRetroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
Reducing the long-term morbidity in testicular cancer survivors represents a major area of interest. External beam radiation therapy and systemic chemotherapy are established treatments for seminoma; however, they are associated with late toxicities such as cardiovascular disease, insulin resistance, and secondary malignancy. Retroperitoneal lymph node dissection (RPLND) is a standard treatment...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1993
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(19930701)72:1<3::aid-cncr2820720103>3.0.co;2-6